ArticleJournal of diabetes investigation2019

Impact of body mass index on the efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes mellitus: A subgroup analysis of 3-month interim results from the Specified Drug Use Results Survey of Ipragliflozin Treatment in Type 2 Diabetic Patients: Long-term Use study.

Kazuyuki Tobe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.